These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29960255)

  • 1. Targeting a hidden site on class A beta-lactamases.
    Avci FG; Altinisik FE; Karacan I; Senturk Karagoz D; Ersahin S; Eren A; Sayar NA; Vardar Ulu D; Ozkirimli E; Sariyar Akbulut B
    J Mol Graph Model; 2018 Sep; 84():125-133. PubMed ID: 29960255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel non-β-lactam inhibitor of β-lactamase TEM-171 based on acylated phenoxyaniline.
    Grigorenko VG; Andreeva IP; Rubtsova MY; Deygen IM; Antipin RL; Majouga AG; Egorov AM; Beshnova DA; Kallio J; Hackenberg C; Lamzin VS
    Biochimie; 2017 Jan; 132():45-53. PubMed ID: 27771370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening, molecular docking, and molecular dynamics simulation approaches for identification of new potential inhibitors of class a β-lactamase enzymes.
    Khademi Dehkordi M; Hoveida L; Fani N
    J Biomol Struct Dyn; 2024 Jul; 42(11):5631-5641. PubMed ID: 37534493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
    Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
    Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communication between the active site and the allosteric site in class A beta-lactamases.
    Meneksedag D; Dogan A; Kanlikilicer P; Ozkirimli E
    Comput Biol Chem; 2013 Apr; 43():1-10. PubMed ID: 23314151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics.
    Galdadas I; Qu S; Oliveira ASF; Olehnovics E; Mack AR; Mojica MF; Agarwal PK; Tooke CL; Gervasio FL; Spencer J; Bonomo RA; Mulholland AJ; Haider S
    Elife; 2021 Mar; 10():. PubMed ID: 33755013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
    Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
    J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evolutionarily conserved allosteric site modulates beta-lactamase activity.
    Avci FG; Altinisik FE; Vardar Ulu D; Ozkirimli Olmez E; Sariyar Akbulut B
    J Enzyme Inhib Med Chem; 2016; 31(sup3):33-40. PubMed ID: 27353461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.
    Chow DC; Rice K; Huang W; Atmar RL; Palzkill T
    ACS Infect Dis; 2016 Dec; 2(12):969-979. PubMed ID: 27756125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the beta-lactamase protein using comparative modelling, drug screening and molecular dynamics studies to understand the resistance of β-lactam antibiotics.
    Alazmi M
    J Mol Model; 2020 Jul; 26(8):200. PubMed ID: 32638150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, SAR and molecular docking study of novel non-β-lactam inhibitors of TEM type β-lactamase.
    Antipin RL; Beshnova DA; Petrov RA; Shiryaeva AS; Andreeva IP; Grigorenko VG; Rubtsova MY; Majouga AG; Lamzin VS; Egorov AM
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1588-1592. PubMed ID: 28237762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into avibactam mediated class C β-lactamase inhibition: competition between reverse acylation and hydrolysis through desulfation.
    Das CK; Nair NN
    Phys Chem Chem Phys; 2018 May; 20(21):14482-14490. PubMed ID: 29785432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening to identify the beta-lactamase CTX-M-9 inhibitors: An in silico effort to overcome antibiotic resistance in E. coli.
    Davari K; Nowroozi J; Hosseini F; Sepahy AA; Mirzaie S
    Comput Biol Chem; 2017 Apr; 67():174-181. PubMed ID: 28129568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling and virtual screening of inhibitors against TEM- and SHV-type-resistant mutants: A multilayer filtering approach.
    Baig MH; Balaramnavar VM; Wadhwa G; Khan AU
    Biotechnol Appl Biochem; 2015; 62(5):669-80. PubMed ID: 25779642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent docking of selected boron-based serine beta-lactamase inhibitors.
    Sgrignani J; Novati B; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2015 May; 29(5):441-50. PubMed ID: 25676821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.
    Zhang Y; Yan Y; Liang L; Feng J; Wang X; Li L; Yang K
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class A β-lactamases and inhibitors: In silico analysis of the binding mode and the relationship with resistance.
    Pereira R; Rabelo VW; Sibajev A; Abreu PA; Castro HC
    J Biotechnol; 2018 Aug; 279():37-46. PubMed ID: 29753682
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sharma R; Jade D; Mohan S; Chandel R; Sugumar S
    J Biomol Struct Dyn; 2021 Nov; 39(18):7123-7137. PubMed ID: 32820691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.